TrialEuropean journal of clinical pharmacology2007

Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.

Marjo J Karjalainen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.